For organisations

Build responsible strengths-first work with us.

We work with organisations, researchers and funders who want to help people recognise strengths, improve support conversations and develop the evidence responsibly.

Explore a partnership

Three ways to work together

Start with the outcome you want to support.

Programme and pilot partners

Explore strengths-first support in practice.

Good fit
Organisations supporting people who may benefit from a strengths-first reflection and conversation.
What we bring
Lux, programme design support, evidence boundaries and a shared learning approach.
What we need
A clear purpose, participant support, an appropriate consent pathway and people who can learn with us.
What we will measure
Agreed participation, delivery, support and learning questions, interpreted within Lux’s evidence boundaries.
First decision
Whether Lux and the proposed setting are a responsible fit, before we discuss scope or delivery.
Discuss a Lux pilot
Research partners

Help answer the questions that matter.

Good fit
Researchers and institutions interested in reliability, validity, fairness, norms or practical utility.
What we bring
A versioned assessment system, defined claim limits and access to the current evidence programme context.
What we need
Methodological expertise, suitable study design, transparent review and disciplined interpretation.
What we will measure
Pre-defined study outcomes, data quality, reliability, validity, fairness or practical utility suited to the research question.
First decision
Whether the research question, evidence gate and governance can support a responsible study path.
Discuss a research partnership
Philanthropic and funding partners

Fund responsible development and evidence.

Good fit
Funders seeking a people-first, evidence-led approach to capability, participation and support.
What we bring
A clear programme purpose, public accountability and disciplined reporting of what evidence supports.
What we need
Patient capital for programme delivery, participant-informed development and staged research.
What we will measure
Agreed programme milestones, use of funds, evidence-development progress and public reporting boundaries.
First decision
Whether the intended outcome, funding fit and reporting expectations align with the programme.
Start a funding conversation

Mutual contribution

Every proposed use starts with purpose, consent and support, not the technology.

Both sides contribute

We bring Lux, programme design support, clear evidence boundaries and a shared learning approach. Partners bring purpose, context, safeguards, expertise or funding suited to the pathway.

Fit comes first

The first decision is whether that combination creates a responsible fit. Scope and delivery come after.

Learning is shared

Roles, scope, learning questions and boundaries are documented together, then reviewed: what happened, what can be said and what should change next.

How it works

A responsible pilot, step by step.

Every proposed use starts with purpose, consent and support. Scroll, or choose a step.

Important boundaries

Useful reflection, not diagnosis or selection.

Lux is descriptive. It is not diagnostic, predictive or a personnel-selection instrument. Proposed uses require clear consent, participant support and reporting suited to the people involved.

Consent

A genuine choice.

The process begins with information about the proposed use and informed consent. Participation should be a genuine choice.

Reporting

The right report for the right reader.

The agreed consent and reporting model sets out who receives each report. Deeper professional reporting is limited to authorised clinicians and used alongside their own judgement.

Lumen

One governed pathway.

Lumen, our secure platform, connects invitation, consent, assessment, governed scoring and reporting. This describes Lumen’s intended role, not any particular deployment, pilot, data location, retention period or live operating environment.

Lux is

  • A strengths-first, descriptive psychological assessment, designed for reflection and conversation.
  • A profile of 360 defined participant-level fields across 20 layers. These are computed fields, not 360 questions or 360 separately validated constructs.
  • Reported by audience: participants receive a carefully curated subset of their profile.

Lux is not

  • Clinically validated, diagnostic or predictive.
  • A basis for personnel selection.
  • A substitute for independent professional judgement.

Good partnership needs both sides

What you get, and what we ask.

What you and your people get
  • Your organisation: Lux, programme design support, clear evidence boundaries and a shared learning approach.
  • Participants: a report written for them, drawn from a carefully curated subset of their profile to support reflection and growth.
  • Authorised clinicians: deeper technical decision support, used alongside participant history, context and independent professional judgement.
  • Everyone: agreed learning questions, interpreted within Lux’s evidence boundaries, and an honest review of what can be said.
What we ask of partners
  • Programme partners: a clear purpose, participant support, an appropriate consent pathway and people who can learn with us.
  • Research partners: methodological expertise, suitable study design, transparent review and disciplined interpretation.
  • Funding partners: patient capital for programme delivery, participant-informed development and staged research.
Explore a partnership

Honest about where the evidence stands

We publish what the evidence currently supports.

Lux is moving through an active, staged evidence-development programme. We state the limits, and strengthen claims only when pre-defined studies produce supporting results. The programme has not yet produced completed Lux-specific validation results.

α .800–.898

Documented internal consistency of the full ten-item Big Five item banks, in a 603,322-response source and reference dataset.

This is source and reference evidence. It is not a count of Lux participants and not proof that every Lux output is valid.

For research partners: eligible participant data enables pre-defined studies, but participant volume alone does not establish validity, reliability, norms, fairness or clinical utility.

Read the evidence position

Practical questions

What decision-makers ask first.

What happens after we get in touch?

First, we decide together whether Lux and the proposed setting are a responsible fit, before discussing scope or delivery.

Can people sign up to Lux directly?

Not through this public website. Lux is currently accessed through a participating organisation or professional. Organisations can contact us to discuss a suitable pilot.

Is taking part voluntary?

Yes. The process begins with information about the proposed use and informed consent. Participation should be a genuine choice.

Who can see a participant’s results?

The agreed consent and reporting model sets out who receives each report. Participants receive a report written for them; deeper professional reporting is limited to authorised clinicians and is used alongside their own judgement.

How long does Lux take, and what support is needed?

Timing and support can depend on the programme and participant context. The inviting organisation should explain the expected commitment, access arrangements and available support before consent.

Can we use Lux to select or assess staff?

No. Lux is not a personnel-selection instrument.

Is Lux a diagnosis or clinical decision?

No. Lux is descriptive, not diagnostic or predictive, and it is not a substitute for independent professional judgement.

Start with fit

Explore a partnership.

Tell us what you want to make possible. The first conversation is about the people, the purpose and whether Lux is a responsible fit.

What happens next

We clarify the people, purpose and question before discussing delivery. Your topic routes your message to the right conversation.

Prefer to support as a donor?

Give to Foundation Nova Diem’s programme delivery, participant-informed development and evidence development. Donate

Send an enquiry

Fields marked with an asterisk are required.

Tell us about your organisation, community, intended purpose, location and timing.

By sending this form, you ask us to use the details in your message to respond. Please do not include sensitive personal or health information. Read our privacy notice.

To keep spam out, we screen messages before they reach our team.